![]() |
| |
| |
| |
| |
| |
| |
|
| TissGeneSummary for SPANXN3 |
Gene summary |
| Basic gene information | Gene symbol | SPANXN3 |
| Gene name | SPANX family, member N3 | |
| Synonyms | CT11.8|SPANX-N3 | |
| Cytomap | UCSC genome browser: Xq27.3 | |
| Type of gene | protein-coding | |
| RefGenes | NM_001009609.3, | |
| Description | cancer/testis antigen family 11, member 8nuclear-associated protein SPAN-Xn3sperm protein associated with the nucleus on the X chromosome N3 | |
| Modification date | 20141207 | |
| dbXrefs | MIM : 300666 | |
| HGNC : HGNC | ||
| Ensembl : ENSG00000189252 | ||
| HPRD : 18092 | ||
| Vega : OTTHUMG00000022582 | ||
| Protein | UniProt: go to UniProt's Cross Reference DB Table | |
| Expression | CleanEX: HS_SPANXN3 | |
| BioGPS: 139067 | ||
| Pathway | NCI Pathway Interaction Database: SPANXN3 | |
| KEGG: SPANXN3 | ||
| REACTOME: SPANXN3 | ||
| Pathway Commons: SPANXN3 | ||
| Context | iHOP: SPANXN3 | |
| ligand binding site mutation search in PubMed: SPANXN3 | ||
| UCL Cancer Institute: SPANXN3 | ||
| Assigned class in TissGDB* | C | |
| Included tissue-specific gene expression resources | HPA,GTEx | |
| Specific-tissues in normal samples (assigned by TissGDB using HPA, TiGER, and GTEx) | Testis | |
| Cancer types related to the specific-tissues in cancer samples (assigned by TissGDB using TCGA) | TGCT | |
| Reference showing the relevant tissue of SPANXN3 | ||
| Description by TissGene annotations | ||
| * Class A consists of genes with literature evidence and is part of the cTissGenes. Class B consists of only cTissGenes without additional evidence. The remaining genes belong to Class C. |
Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
| GO ID | GO term | PubMed ID |
| Top |
| TissGeneExp for SPANXN3 |
Gene expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1))(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
![]() |
Gene isoform expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1))(TCGA pan-cancer tcga_rsem_isoform_tpm, version 2016-09-01) |
![]() |
Gene expressions across normal tissues of GTEx data(GTEx GTEx_Analysis_v6_RNA-seq_RNA-SeQCv1.1.8_gene_rpkm.gct) - Here, we shows the matched tissue types only among our 28 cancer types. |
![]() |
Different expressions across 14 cancer types with more than 10 samples between matched tumors and normals (X-axis: cancer type and Y-axis: log2(norm_counts+1))(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
![]() |
| - Significantly differentially expressed cancer types and information. (|Fold change|>1 and FDR<0.05) |
| Cancer type | Mean(exp) in tumor | Mean(exp) in matched normal | Log2FC | P-val. | FDR |
| Top |
| TissGene-miRNA for SPANXN3 |
Significantly anti-correlated miRNAs of TissGene across 28 cancer types(Gene-miRNA relations from TargetScanHuman Relsease 7.1, Conserved_Site_Context_Scores.txt.zip, 06.01.2016) (TCGA IlluminaHiSeq_miRNASeq, log2(RPM+1) data, version 2016-11-21) (TCGA IlluminaHiSeq_RNASeqV2, log2(normalized_count+1) data, version 2016-08-16) (Spearman’s Rank Correlation (p-value<0.05 and coefficient<-0.25)) |
| Cancer type | miRNA id | miRNA accession | P-val. | Coeff. | # samples |
| Top |
| TissGeneMut for SPANXN3 |
| TissGeneSNV for SPANXN3 |
nsSNV counts per each loci.Different colors of circles represent different cancer types. Circle size denotes number of samples. (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) * Click on the image to enlarge it in a new window. |
![]() |
![]() |
Somatic nucleotide variants of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of mutated samples) The numbers in parentheses are numbers of samples with mutation (nsSNVs). (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) |
![]() |
| - nsSNVs sorted by frequency. |
| AAchange | Cancer type | # samples |
| p.D114Y | UCEC | 2 |
| p.K43N | COAD | 1 |
| p.Q67* | SKCM | 1 |
| p.G107E | SKCM | 1 |
| p.C105F | LUSC | 1 |
| p.N64H | UCEC | 1 |
| p.E48K | SKCM | 1 |
| p.V34L | LUAD | 1 |
| p.K62N | SKCM | 1 |
| p.D90Y | HNSC | 1 |
| p.S134F | SKCM | 1 |
| p.T13S | STAD | 1 |
| p.G94E | SKCM | 1 |
| p.S134T | SKCM | 1 |
| p.E26D | LUAD | 1 |
| p.K59N | UCEC | 1 |
| p.S122L | COAD | 1 |
| p.S92F | SKCM | 1 |
| p.K22T | UCEC | 1 |
| p.L91F | READ | 1 |
| p.E11* | HNSC | 1 |
| p.D99N | STAD | 1 |
| p.G10V | ACC | 1 |
| p.S77F | BLCA | 1 |
| p.L41F | LUAD | 1 |
| p.Q123R | LUAD | 1 |
| p.S6F | SKCM | 1 |
| p.P4L | SKCM | 1 |
| p.E18K | ESCA | 1 |
| p.E132Q | ESCA | 1 |
| p.G60V | COAD | 1 |
| p.L91I | READ | 1 |
| p.I51M | READ | 1 |
| p.S134C | OV | 1 |
| p.T13A | LUAD | 1 |
| p.T5N | ACC | 1 |
| p.I81T | BLCA | 1 |
| p.S77F | SKCM | 1 |
| p.Q72K | STAD | 1 |
| p.S117* | LUAD | 1 |
| p.E87K | UCEC | 1 |
| p.V54L | LUAD | 1 |
| p.P80L | SKCM | 1 |
| p.E111K | SKCM | 1 |
| p.E100K | LUSC | 1 |
| p.S15T | LUAD | 1 |
| p.P50Q | LUAD | 1 |
| p.K22R | UCS | 1 |
| p.S117* | UCEC | 1 |
| p.E132G | STAD | 1 |
| p.E75D | BLCA | 1 |
| Top |
| TissGeneCNV for SPANXN3 |
Copy number variations of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of CNV samples)(TCGA Gistic2_CopyNumber_Gistic2_all_data_by_genes, Gistic2 copy number data, version 2016-08-16) |
![]() |
| Top |
| TissGeneFusions for SPANXN3 |
Fusion genes including TissGene (ChimerDB 3.0, 2016-12-01 and TCGA fusion Portal 2015-12-01) |
| Database | Src | Cancer type | Sample | Fusion gene | ORF | 5'-gene BP | 3'-gene BP |
| Top |
| TissGeneNet for SPANXN3 |
Co-expressed gene networks based on protein-protein interaction data (CePIN)(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (PINA2 ppi data) |
| Top |
| TissGeneProg for SPANXN3 |
Kaplan-Meier plots with logrank tests of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image to enlarge it in a new window. |
![]() |
Kaplan-Meier plots with logrank test of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
![]() |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
![]() |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
![]() |
| Top |
| TissGeneClin for SPANXN3 |
| TissGeneDrug for SPANXN3 |
Drug information targeting TissGene (DrugBank Version 5.0.6, 2017-04-01) |
| DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
| Top |
| TissGeneDisease for SPANXN3 |
Disease information associated with TissGene (DisGeNet, 2016-06-01) |
| Disease ID | Disease name | # pubmeds | Source |